Trials / Completed
CompletedNCT04745897
Accessibility of the World Health Organization's eTB Catalogue of Recommendations
Comparing the Accessibility of the World Health Organization's Tuberculosis Guidelines to the eTB Catalogue of Recommendations: A Two-Arm Superiority Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 244 (actual)
- Sponsor
- McMaster University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The World Health Organization's Global Tuberculosis Programme (WHO-GTB) issues evidence-informed guideline recommendations on tuberculosis (TB). These recommendations are used by decision-makers, guideline developers and other stakeholders. In an effort to improve the accessibility and usability of these recommendations, a new eTB catalogue of recommendations has been developed. This study aims to compare the accessibility of the new eTB catalogue to the earlier method of accessing recommendations directed through the general WHO website.
Detailed description
This is a two-arm superiority randomized controlled trial. The primary objective is to compare the accessibility of information between the eTB catalogue (intervention) and WHO TB (comparison). Secondary outcomes include understanding of the information, satisfaction of catalogue presentation, and preference toward the catalogue. Current and potential users of TB recommendations will be recruited. Data will be collected using a survey with demographic questions and subsequent 1:1 randomization to the intervention. Superiority will be declared if the mean difference in accessibility is 0.5 or greater for the intervention arm on the seven-point Likert scale.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | eTB Catalogue of Recommendations (eTB) | eTB Catalogue of Recommendations (eTB) |
| OTHER | World Health Organization Tuberculosis Website (WHO TB) | World Health Organization Tuberculosis Website (WHO TB) |
Timeline
- Start date
- 2021-02-26
- Primary completion
- 2021-08-29
- Completion
- 2021-08-29
- First posted
- 2021-02-09
- Last updated
- 2021-12-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04745897. Inclusion in this directory is not an endorsement.